Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA IND. SWIFT JUBILANT PHARMOVA /
IND. SWIFT
 
P/E (TTM) x -2,652.6 3.3 - View Chart
P/BV x 1.7 - - View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 JUBILANT PHARMOVA    IND. SWIFT
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
IND. SWIFT
Mar-23
JUBILANT PHARMOVA /
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs49615 3,387.2%   
Low Rs2697 4,135.4%   
Sales per share (Unadj.) Rs394.475.9 519.8%  
Earnings per share (Unadj.) Rs-4.14.8 -84.7%  
Cash flow per share (Unadj.) Rs30.710.1 304.0%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs338.6-130.1 -260.2%  
Shares outstanding (eoy) m159.2854.16 294.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.1 695.9%   
Avg P/E ratio x-93.82.2 -4,268.8%  
P/CF ratio (eoy) x12.41.0 1,189.7%  
Price / Book Value ratio x1.1-0.1 -1,390.0%  
Dividend payout %-122.70-   
Avg Mkt Cap Rs m60,873572 10,637.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,660637 3,397.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,8174,110 1,528.6%  
Other income Rs m383119 323.3%   
Total revenues Rs m63,2014,228 1,494.8%   
Gross profit Rs m7,3171,026 713.1%  
Depreciation Rs m5,540287 1,932.6%   
Interest Rs m1,882598 314.9%   
Profit before tax Rs m278260 106.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9270-   
Profit after tax Rs m-649260 -249.2%  
Gross profit margin %11.625.0 46.6%  
Effective tax rate %333.50-   
Net profit margin %-1.06.3 -16.3%  
BALANCE SHEET DATA
Current assets Rs m37,6242,734 1,376.2%   
Current liabilities Rs m17,7249,363 189.3%   
Net working cap to sales %31.7-161.3 -19.6%  
Current ratio x2.10.3 727.0%  
Inventory Days Days25115 21.3%  
Debtors Days Days56929 6.0%  
Net fixed assets Rs m71,6683,758 1,906.9%   
Share capital Rs m159108 146.9%   
"Free" reserves Rs m53,772-7,155 -751.5%   
Net worth Rs m53,931-7,047 -765.3%   
Long term debt Rs m31,1044,031 771.6%   
Total assets Rs m109,2926,492 1,683.5%  
Interest coverage x1.11.4 79.9%   
Debt to equity ratio x0.6-0.6 -100.8%  
Sales to assets ratio x0.60.6 90.8%   
Return on assets %1.113.2 8.5%  
Return on equity %-1.2-3.7 32.6%  
Return on capital %2.5-28.4 -8.9%  
Exports to sales %068.8 0.0%   
Imports to sales %4.15.3 77.2%   
Exports (fob) Rs mNA2,827 0.0%   
Imports (cif) Rs m2,564217 1,180.7%   
Fx inflow Rs m7,1002,947 240.9%   
Fx outflow Rs m2,564313 818.1%   
Net fx Rs m4,5362,634 172.2%   
CASH FLOW
From Operations Rs m6,607730 904.5%  
From Investments Rs m-5,444-293 1,855.2%  
From Financial Activity Rs m-1,567-466 336.5%  
Net Cashflow Rs m301-29 -1,054.3%  

Share Holding

Indian Promoters % 47.4 55.6 85.3%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 0.0 -  
FIIs % 20.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 44.4 111.0%  
Shareholders   86,588 14,219 609.0%  
Pledged promoter(s) holding % 0.0 42.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Jubilant Pharmova vs IND. SWIFT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs IND. SWIFT Share Price Performance

Period Jubilant Pharmova IND. SWIFT S&P BSE HEALTHCARE
1-Day -0.11% -6.93% -1.15%
1-Month -6.06% -1.04% -5.20%
1-Year 88.91% 157.88% 57.17%
3-Year CAGR -7.37% 60.54% 18.07%
5-Year CAGR -7.55% 25.68% 18.83%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the IND. SWIFT share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of IND. SWIFT.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of IND. SWIFT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.